Seems like a non issue for ANP holders
From Pharmaphorum.com - ”The company gave little else away but added that there were no new or emerging safety signals identified, meaning that the issue is likely to be that the drug simply wasn’t working in the placebo-controlled trial.”
Chart, page-3333
-
- There are more pages in this discussion • 2,573 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
Add PER (ASX) to my watchlist
|
|||||
Last
7.0¢ |
Change
-0.001(1.41%) |
Mkt cap ! $63.10M |
Open | High | Low | Value | Volume |
7.1¢ | 7.1¢ | 6.9¢ | $34.01K | 486.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 132919 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 78000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 80000 | 0.069 |
4 | 134427 | 0.068 |
3 | 224490 | 0.067 |
1 | 15000 | 0.066 |
4 | 32000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 78000 | 1 |
0.075 | 13371 | 1 |
0.078 | 75476 | 2 |
0.079 | 175123 | 2 |
0.080 | 287231 | 3 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |